By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company PURE Bioscience, Inc.

PURE Bioscience, Inc. (PURE)

OTC Currency in USD
$0.09
+$0.01
+9.04%
Last Update: 11 Sept 2025, 19:37
$10.13M
Market Cap
-3.58
P/E Ratio (TTM)
Forward Dividend Yield
$0.05 - $0.21
52 Week Range

PURE Stock Price Chart

Explore PURE Bioscience, Inc. interactive price chart. Choose custom timeframes to analyze PURE price movements and trends.

PURE Company Profile

Discover essential business fundamentals and corporate details for PURE Bioscience, Inc. (PURE) to support your stock research and investment decisions.

Sector

Consumer Defensive

Industry

Household & Personal Products

IPO Date

8 Aug 1996

Employees

11.00

CEO

Robert F. Bartlett

Description

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

PURE Financial Timeline

Browse a chronological timeline of PURE Bioscience, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 16 Mar 2026

Upcoming earnings on 15 Dec 2025

Upcoming earnings on 27 Oct 2025

Earnings released on 16 Jun 2025

EPS came in at -$0.01 , while revenue for the quarter reached $491.00K .

Earnings released on 17 Mar 2025

EPS came in at -$0.01 , while revenue for the quarter reached $391.00K .

Earnings released on 16 Dec 2024

EPS came in at -$0.01 , while revenue for the quarter reached $556.00K .

Earnings released on 29 Oct 2024

EPS came in at -$0.01 , while revenue for the quarter reached $474.00K .

Earnings released on 14 Jun 2024

EPS came in at -$0.01 , while revenue for the quarter reached $441.00K .

Earnings released on 18 Mar 2024

EPS came in at -$0.01 , while revenue for the quarter reached $326.00K .

Earnings released on 14 Dec 2023

EPS came in at -$0.01 , while revenue for the quarter reached $722.00K .

Earnings released on 30 Oct 2023

EPS came in at -$0.03 , while revenue for the quarter reached $602.00K .

Earnings released on 14 Jun 2023

EPS came in at -$0.01 , while revenue for the quarter reached $407.00K .

Earnings released on 17 Mar 2023

EPS came in at -$0.01 , while revenue for the quarter reached $397.00K .

Earnings released on 14 Dec 2022

EPS came in at -$0.01 , while revenue for the quarter reached $471.00K .

Earnings released on 28 Oct 2022

EPS came in at -$0.01 , while revenue for the quarter reached $412.00K .

Earnings released on 14 Jun 2022

EPS came in at -$0.01 , while revenue for the quarter reached $524.00K .

Earnings released on 15 Mar 2022

EPS came in at -$0.01 , while revenue for the quarter reached $416.00K .

Earnings released on 15 Dec 2021

EPS came in at -$0.01 , while revenue for the quarter reached $501.00K .

Earnings released on 28 Oct 2021

EPS came in at -$0.01 , while revenue for the quarter reached $859.00K .

Earnings released on 15 Jun 2021

EPS came in at -$0.01 , while revenue for the quarter reached $561.00K .

Earnings released on 15 Mar 2021

EPS came in at -$0.01 , while revenue for the quarter reached $916.00K .

Earnings released on 15 Dec 2020

EPS came in at -$0.00 , while revenue for the quarter reached $1.59M .

Earnings released on 8 Oct 2020

EPS came in at $0.02 , while revenue for the quarter reached $3.95M .

PURE Stock Performance

Access detailed PURE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run